HSPG2 and neoplasm: Generally, when PDGFR is activated by PDGF stimulation, it can interact with and activate proteins with SH2 domains, subsequently activating the PI3K, Ras-MAPK and phospholipase γC (PLC) pathways and contributing to tumor growth and progression [42].